BRF S.A. (BRFS)
시가총액: 5.86B
국가: Brazil
산업: #Meat_Poultry_Fish
섹터: #Consumer_Staples
홈페이지: https://www.brf-global.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 2.79B / 2.63B / 6.1% / -79.1% / -8.2%
2412: 3.04B / 2.94B / 3.4% / -78.9% / 13.4%
2409: 2.68B / 2.75B / -2.5% / -80.6% / -2.2%
2406: 2.74B / 2.52B / 8.7% / -77.6% / -79.5%
2403: 13.38B / -- / -- / 1.5% / -7.3%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.0866 / 0.075 / 15.5% / -71.1% / -41.0%
2412: 0.1469 / 0.1205 / 21.9% / -- / 26.1%
2409: 0.1165 / 0.0862 / 35.2% / 148.5% / -2.5%
2406: 0.1195 / 0.0734 / 62.8% / 109.5% / -60.2%
2403: 0.3 / -- / -- / 131.2% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 53.62B(-0.4%) / -1.49(50.5%)
2212: 53.81B(11.3%) / -3.01(-678.8%)
2112: 48.34B(22.5%) / 0.52(-68.1%)
2012: 39.47B(--) / 1.627758(--)

#BRFS

- 사업요약: BRF S.A. raises, produces, and slaughters poultry and pork for processing, production, and sale of fresh meat, processed products, pasta, margarine, pet food, and other products. The company provides frozen who...

Cosan S.A. (CSAN)
시가총액: 2.53B
국가: Brazil
산업: #Retail_Auto_Dealers_and_Gas_Stations
섹터: #Consumer_Discretionary
홈페이지: https://www.cosan.com.br

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 7.29B / 7.23B / 0.8% / 281.7% / -7.3%
2412: 7.86B / 7.15B / 9.9% / -17.9% / 291.0%
2409: 2.01B / 7.26B / -72.3% / -80.4% / 2.0%
2406: 1.97B / 7.15B / -72.4% / -80.3% / 3.1%
2403: 1.91B / 6.98B / -72.6% / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.0826 / 0.4454 / -118.5% / -179.4% / -173.4%
2412: 0.1126 / 0.2211 / -49.1% / -- / 12.5%
2409: 0.1001 / 0.3368 / -70.3% / -93.1% / 257.6%
2406: -0.0635 / 0.0505 / -225.7% / 97.2% / -161.1%
2403: 0.104 / 0.1041 / -0.1% / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 39.47B(-0.7%) / 2.3004(-8.2%)
2212: 39.74B(53.6%) / 2.5056(-81.7%)
2112: 25.87B(26.6%) / 13.7164(639.5%)
2012: 20.44B(--) / 1.8548(--)

#CSAN

- 사업요약: Cosan S.A. engages in the fuel distribution business. It operates through Raízen, Compass, Moove, Rumo, and Radar segments. The company's Raízen segment engages in ...

Molecular Partners AG (MOLN)
시가총액: 141.15M
국가: Switzerland
산업: #Biotechnology_Biological_Products_No_Diagnostic_Substances
섹터: #Health_Care
홈페이지: https://www.molecularpartners.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / 0.00 / -- / -100.0% / --
2412: -- / 237.32K / -- / -- / --
2409: 415.31K / 830.61K / -50.0% / -83.7% / -56.2%
2406: 949.27K / 884.52K / 7.3% / 128.7% / -65.3%
2403: 2.74M / -- / -- / -10.2% / 165.3%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.5377 / -0.4211 / -27.7% / -58.1% / --
2412: -- / -0.6521 / -- / -- / --
2409: -0.6288 / -- / -- / -79.7% / --
2406: -- / -- / -- / -- / --
2403: -0.34 / -- / -- / 24.4% / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 7.04M(-96.3%) / --(--)
2212: 189.56M(1931.7%) / 3.54(271.8%)
2112: 9.33M(-0.1%) / -2.06(17.9%)
2012: 9.34M(--) / -2.51(-48.5%)

#MOLN

- 사업요약: Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The com...

Presidio Property Trust, Inc. (SQFT)
시가총액: 7.79M
국가: United States
산업: #Real_Estate_Investment_Trusts
섹터: #Real_Estate
홈페이지: https://www.presidiopt.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 4.03M / 5.2M / -22.5% / -- / --
2412: -- / 5M / -- / -- / --
2409: -- / 4.8M / -- / -- / --
2406: 4.6M / 4.5M / 2.2% / 1.2% / --
2403: -- / 4.60M / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.13 / -- / -- / -- / --
2412: -- / -- / -- / -- / --
2409: -- / -- / -- / -- / --
2406: -0.1 / -- / -- / 33.3% / --
2403: -- / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 17.64M(-0.7%) / 0.68(219.3%)
2212: 17.76M(-7.6%) / -0.57(-23.9%)
2112: 19.23M(-21.0%) / -0.46(45.9%)
2012: 24.35M(--) / -0.85(--)

#SQFT

- 사업요약: Presidio Property Trust, Inc. (“we”, “our”, “us” or the “Company”) is an internally-managed real estate investment trust (“REIT”), with holdings in office, industrial, retail and model home properties. We were incorporated in the State of California on September 28, 1999, and in August 2010, w...

Cardiol Therapeutics Inc. (CRDL)
시가총액: 93.95M
국가: Canada
산업: #Biotechnology_Biological_Products_No_Diagnostic_Substances
섹터: #Health_Care
홈페이지: https://www.cardiolrx.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / 0.00 / -- / -- / --
2412: -- / 0.00 / -- / -- / --
2409: -- / 0.00 / -- / -- / --
2406: 0.00 / 0.00 / -- / -- / --
2403: 0.0 / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.0715 / -0.0909 / 21.3% / 48.9% / --
2412: -- / -0.0949 / -- / -- / --
2409: -- / -0.0832 / -- / -- / --
2406: -0.073 / -0.1034 / 29.4% / 39.2% / 47.9%
2403: -0.14 / -- / -- / -27.3% / --

- 연간 매출(YoY%), EPS(YoY%)
2212: 0.0(-100.0%) / -0.49(32.9%)
2112: 78760.0(--) / -0.73(-5.8%)
2012: 0.0(--) / -0.69(-30.2%)
1912: 0.0(--) / -0.53(--)

#CRDL

- 사업요약: Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II...

So-Young International Inc. (SY)
시가총액: 81.58M
국가: China
산업: #EDP_Services
섹터: #Technology
홈페이지: https://www.soyoung.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 297.27M / -- / -- / -6.6% / -19.5%
2412: 369.21M / 402.58M / -8.3% / -5.5% / -0.7%
2409: 371.83M / 357.38M / 4.0% / -3.5% / -8.7%
2406: 407.4M / 367.99M / 10.7% / -1.1% / 28.0%
2403: 318.30M / 300.41M / 6.0% / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.32 / -- / -- / -252.4% / 95.8%
2412: -7.7 / 0.09 / -8655.6% / -4452.2% / -3950.0%
2409: 0.2 / 0.26 / -23.1% / 8.3% / -16.7%
2406: 0.24 / 0.25 / -4.0% / 1140.0% / 14.3%
2403: 0.21 / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)
2312: 1.5B(19.1%) / 0.207692(134.2%)
2212: 1.26B(-25.7%) / -0.607692(-690.0%)
2112: 1.69B(30.7%) / -0.076923(-244.3%)
2012: 1.29B(--) / 0.053316(--)

#SY

- 사업요약: So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic ...

Mastech Digital, Inc. (MHH)
시가총액: 100.03M
국가: United States
산업: #Professional_Services
섹터: #Consumer_Discretionary
홈페이지: https://www.mastechdigital.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 48.3M / 48.2M / 0.2% / 3.2% / -4.8%
2412: 50.75M / 49.24M / 3.1% / 10.2% / -2.1%
2409: 51.84M / 49.2M / 5.4% / 8.5% / 4.7%
2406: 49.53M / 48.1M / 3.0% / -5.1% / 5.8%
2403: 46.82M / -- / -- / -15.0% / 1.7%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.06 / 0.17 / -64.7% / 700.0% / -73.9%
2412: 0.23 / 0.115 / 100.0% / 150.0% / 0.0%
2409: 0.23 / 0.125 / 84.0% / 2200.0% / 21.1%
2406: 0.19 / 0.075 / 153.3% / 200.0% / 2000.0%
2403: -0.01 / -- / -- / -150.0% / 97.8%

- 연간 매출(YoY%), EPS(YoY%)
2312: 201.1M(-17.0%) / -0.61(-184.7%)
2212: 242.24M(9.1%) / 0.72(-29.4%)
2112: 222.01M(14.4%) / 1.02(22.9%)
2012: 194.1M(--) / 0.83(--)

#MHH

- 사업요약: Mastech Digital, Inc., together with its subsidiaries, provides digital transformation IT services to large, medium-sized, and small companies in the United States. The company opera...

Flowers Foods, Inc. (FLO)
시가총액: 3.6B
국가: United States
산업: #Packaged_Foods
섹터: #Consumer_Staples
홈페이지: https://www.flowersfoods.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 1.55B / 1.6B / -3.1% / -1.7% / 39.6%
2412: 1.11B / 1.13B / -1.8% / -1.7% / -6.7%
2409: 1.19B / 1.2B / -0.8% / -0.8% / -3.3%
2406: 1.23B / 1.24B / -0.8% / 0.2% / -22.0%
2403: 1.58B / -- / -- / -- / 39.7%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: 0.35 / 0.38 / -7.9% / 2.9% / 59.1%
2412: 0.22 / 0.21 / 4.8% / 29.8% / -33.3%
2409: 0.33 / 0.29 / 13.8% / 250.0% / -8.3%
2406: 0.36 / 0.33 / 9.1% / 20.0% / 5.9%
2403: 0.34 / -- / -- / -- / 100.5%

- 연간 매출(YoY%), EPS(YoY%)
2312: 5.09B(5.9%) / 0.58(-45.8%)
2212: 4.81B(11.0%) / 1.07(10.3%)
2112: 4.33B(-1.3%) / 0.97(34.8%)
2012: 4.39B(--) / 0.719828(--)

#FLO

- 사업요약: Flowers Foods, Inc. produces and markets packaged bakery food products in the United States. Its principal products include fresh breads, buns, rolls, snack items, bagels, English muffins, and tortillas, as well as frozen breads a...

Brady Corporation (BRC)
시가총액: 3.64B
국가: United States
산업: #Miscellaneous_manufacturing_industries
섹터: #Consumer_Discretionary
홈페이지: https://www.bradyid.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2504: 382.59M / 386.61M / -1.0% / 11.4% / 7.3%
2501: 356.68M / 362.11M / -1.5% / 10.6% / -5.4%
2410: 377.07M / 365.85M / 3.1% / 13.6% / 9.8%
2407: 343.4M / 351.74M / -2.4% / -0.7% / 0.0%
2404: 343.38M / -- / -- / 1.9% / 6.4%

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2504: 1.22 / 1.23 / -0.8% / 16.2% / 22.0%
2501: 1.0 / 1.04 / -3.8% / 11.1% / -10.7%
2410: 1.12 / 1.1 / 1.8% / 15.5% / -5.9%
2407: 1.19 / 1.11 / 7.2% / -- / 13.3%
2404: 1.05 / -- / -- / 9.4% / 16.7%

- 연간 매출(YoY%), EPS(YoY%)
2307: 1.33B(2.3%) / 3.51(21.0%)
2207: 1.3B(13.7%) / 2.9(17.4%)
2107: 1.14B(5.9%) / 2.47(17.1%)
2007: 1.08B(--) / 2.11(--)

#BRC

- 사업요약: Brady Corporation manufactures and supplies identification solutions (IDS) and workplace safety (WPS) products to identify and protect premises, products, and people in the United States and internatio...

OS Therapies Incorporated (OSTX)
시가총액: 35.96M
국가:
산업: #Biotechnology_Pharmaceutical_Preparations
섹터: #Health_Care
홈페이지: https://ostherapies.com

- 분기 매출(공시, 예측, 서프, YoY, QoQ)
2503: 0.00 / -- / -- / -- / --
2412: 0.00 / -- / -- / -- / -100.0%
2409: 300K / -- / -- / -- / --

- 분기 EPS(공시, 예측, 서프, YoY, QoQ)
2503: -0.18 / -- / -- / -- / -28.6%
2412: -0.14 / -- / -- / -- / 22.2%
2409: -0.18 / -- / -- / -- / --

- 연간 매출(YoY%), EPS(YoY%)

#OSTX

- 사업요약: OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.